Nashville, TNNCT07214597Now EnrollingIRB Ready

Postpartum Depression (PPD) Clinical Trial in Nashville, TN

Access cutting-edge postpartum depression (ppd) treatment through this clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.

Sponsored by Vanderbilt University Medical Center

Quick Self-Assessment

See if you qualify for this Nashville location

Preparing your pre-screening questions…

Expert Care in Nashville

Access postpartum depression (ppd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related postpartum depression (ppd) treatment provided free

Apply for This Nashville Location

Check if you qualify for this postpartum depression (ppd) clinical trial in Nashville, TN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Nashville

    Convenient for TN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Nashville site if eligible
  4. 4Begin participation

About This Postpartum Depression (PPD) Study in Nashville

The study's objective is to conduct a Phase II randomized controlled trial examining the preliminary efficacy of the VoiceLove app compared to usual care on maternal postpartum depression in mothers with infants admitted to the Neonatal Intensive Care Unit (NICU). Primary aim: Assess the effects of VoiceLove on maternal postpartum depression, measured by the Edinburgh Postnatal Depression Scale (EPDS). The estimates from this study will be used for a future definitive Phase III trial. Secondary aim: Assess feasibility, acceptability, and patterns of communication and engagement among mothers, partners, and NICU clinicians during the NICU hospitalization, measured through app usage metrics, satisfaction surveys, and qualitative interviews. Additionally, we will evaluate effects of infant length of stay.

Sponsor: Vanderbilt University Medical Center

Who Can Participate

Inclusion Criteria

Admitted to the neonatal intensive care unit (NICU)
Not readmitted after discharge from the NICU
Expected to survive at least 2 weeks
Expected to be admitted to the NICU for at least 2 weeks
Singleton gestation
Age ≥ 18 years old
English speaking
Mother is the biological mother of the infant admitted to the NICU
Postpartum day 4 or less
Partner (NOTE: Partner enrollment is not required)
Mother agrees to partner's participation
Designated by mother as support person with infant access

Exclusion Criteria

Infant a. Re-admission to NICU
No access to an Android or iOS smartphone
Unwilling to download the VoiceLove NICU app to their personal smartphone and unwilling to accept the terms and conditions of the VoiceLove app
No personal email address
Incarcerated at time of delivery or postpartum
Inability to obtain informed consent i. Patient's clinician refuses enrollment of the patient ii. Patient is either mentally (acute psychosis) or physically (intubated or critically ill in the ICU) unable to provide informed consent f. Unable to approach the patient (staffing, patient unavailable) g. Mother is not the intended parent (plans adoption, is a surrogate, will not have custody of the infant)
Partner (NOTE: Partner enrollment is not required)
Age \< 18 years old
Not English speaking
Inability to obtain informed consent
No access to an Android or iOS smartphone that is different from the mother's smartphone
No access to an email address that is different from the mother's email address
Unwilling to download the VoiceLove NICU app to their personal smartphone and unwilling to accept the terms and conditions of the VoiceLove app

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Nashville?

Yes, this clinical trial (NCT07214597) has an active research site in Nashville, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Postpartum Depression (PPD) Treatment Options in Nashville, TN

If you're searching for postpartum depression (ppd) treatment options in Nashville, TN, this clinical trial (NCT07214597) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Nashville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced postpartum depression (ppd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all postpartum depression (ppd) clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Nashville, TN

See all parkinsons disease clinical trials recruiting in Nashville — not just this study.

Browse Parkinsons Disease Trials in Nashville

Ready to Join in Nashville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Nashville, TN